Beruflich Dokumente
Kultur Dokumente
C H A P T E R
B A C K G R O U N D
30
C H A P T E R
T H E
C A N C E R
P R O C E S S
31
P A R T
B A C K G R O U N D
32
C H A P T E R
T H E
C A N C E R
P R O C E S S
several types of genes including oncogenes and tumour suppressor genes (box 2.2), and factors in the cellular environment that influence their expression. Maintenance of the
DNA sequence and structure as cells divide is essential: several cellular mechanisms exist to ensure this is achieved.
process called phosphorylation. A regulated process of phosphorylation and dephosphorylation is necessary for the
appropriate initiation, transmission, and cessation of signals.
33
P A R T
Box 2.1
B A C K G R O U N D
34
division (see 2.5.1), so maintaining the particular structural and functional characteristics of the cells of specific
tissues.
Dietary constituents contribute to epigenetic modulation
of promoter regions in both normal and malignant cells. For
example, dietary folate and other methyl-donors such as
choline, methionine, and betaine are essential for DNA
synthesis and epigenetic regulation of DNA. Appropriate
gene expression is maintained by appropriate patterns of
methylation; folate is an important determinant of normal
methylation. In addition, dietary constituents such as genistein, which do not provide methyl groups, have also been
reported to modify DNA methylation.
Imbalances or lack of specific dietary constituents may
potentially increase the risk of cancer by inducing an imbalance in DNA precursors, leading to altered DNA synthesis
and repair, and may impair appropriate patterns of DNA
methylation, with consequences for gene expression. For
example, inadequate folate availability means cells tend to
incorporate uracil into DNA in place of thymine. Global
hypomethylation of DNA is an early epigenetic event in cervical carcinogenesis, and the degree of hypomethylation
increases with the grade of cervical cancer.18 19 Global
hypomethylation of DNA and site-specific hypermethylation
may also be relevant in colorectal cancer.20 A host of bioactive food constituents from alcohol to zinc has been
reported to influence DNA methylation patterns.
Nevertheless, it remains to be determined how important
these changes are in the overall cancer process. The potential cancer-protective effects of green, leafy vegetables (see
chapter 4.2) are often attributed to their folate content.
Folates function as a coenzyme in the metabolism of singlecarbon compounds for nucleic acid synthesis and amino acid
metabolism.
C H A P T E R
T H E
C A N C E R
P R O C E S S
2.2.4 Differentiation
Cells become specialised to perform their particular function
through a process known as differentiation.
Although each cell within the body contains the entire
genome with the same genes, only some genes are active in
any one cell at any one time. Gene expression controls the
subset of genes expressed and the timing of expression, and
this distinguishes one cell type from another by determining their particular structure and function.
Hundreds of different cell types arise from one fertilised
egg during development; this is achieved by proliferation
and differentiation of stem cells. Stem cells are unspecialised
but can give rise to different specialised cell types. A small
population of cells within the tumour mass of several forms
of human cancer, which have both the properties of stem
cells and also the characteristics of transformed cells, may
be important for the development of these tumours. As yet,
our understanding of cancer stem cells is basic, although the
concept was proposed as early as 1875.22 Several groups have
now isolated and identified cancer stem cells in both
haematopoietic and epithelial cancers, including cancers of the
breast,23 brain,24 25 ovary,26 prostate,27 colon,28 and stomach.29
It is clear that subtle changes in exposure to bioactive food
constituents can have a profound effect on the differentiation
of these cells.
In early embryos, proliferation of embryonic stem cells
increases the total number of cells. As the organism develops, cells differentiate and become specialised to their particular function. Transcription factors specific to that cell type
turn on genes for that particular lineage of cells, so determining its structure and function.
At various stages of differentiation, cells become sensitive
Box 2.2
to different growth factors. In the cancer process, one characteristic of cells that are accumulating DNA damage is that
they become de-differentiated and undergo epithelialmesenchymal transition (EMT), characterised by loss of
cell adhesion and increased cell mobility. In addition, during differentiation, other genes can be silenced by chromatin
modification, including DNA methylation and histone modifications such as methylation and acetylation (see 2.2.2).
Stem cells are found among differentiated cells in almost
all adult tissues, where they maintain and regenerate tissues.
Examples include haemopoietic stem cells for continuous
generation of red and white blood cells, and stem cells in
the basal layer of the epidermis and at the base of hair follicles in the skin, which can give rise to keratinocytes and
hair follicles. Cellular differentiation also continues in solid
tissues such as mammary tissue, which during pregnancy differentiates for later milk production. A systematic review has
shown that long-chain n-3 polyunsaturated fatty acids
(PUFAs) in fish oils promote differentiation of colonic epithelial cells.30 31 Vitamin D and retinoic acid may also promote
differentiation of cells.
2.2.5 DNA damage and repair
Each time a cell divides into two new daughter cells, there
is potential for an error in replication of the DNA (see 2.5.1).
These mutations result in non-functioning genes or in proteins with altered amino acid sequences that can change cell
function.
DNA is continuously exposed to damage from products of
normal intracellular metabolism, including reactive oxygen
species, hydroxyl radicals, and hydrogen peroxide; and also
to damage from external factors such as ultra-violet (UV)
35
P A R T
36
B A C K G R O U N D
C H A P T E R
Box 2.3
T H E
C A N C E R
P R O C E S S
37
P A R T
should add up to 100 per cent. This is not so. Reasonable estimates for a number of separate or interactive factors may add
up to well over 100 per cent because of the interactions.
2.4.1 Endogenous causes
2.4.1.1 Inherited germ line mutations
38
B A C K G R O U N D
C H A P T E R
Box 2.4
T H E
C A N C E R
P R O C E S S
Lifetime exposure to oestrogen increased by early menarche, late menopause, not bearing children, and late (over
30) first pregnancy raises the risk of, and may be seen as
a cause of, breast, ovarian, and endometrial cancers in
women. The reverse also applies: a reduction in lifetime
exposure to oestrogen due to late menarche, early menopause, bearing children, and early pregnancy may reduce the
risk of hormone-related cancers. Age at menarche and
menopause are influenced by nutrition, with high-energy
diets leading to early puberty and late menopause, and lowenergy diets delaying puberty and advancing menopause.
The oral combined contraceptive pill (containing both
oestrogen and progesterone) has been estimated to halve the
risk of ovarian cancer, if taken for 5 years or more.96 This
protective effect can last for up to 15 years after women stop
taking these oral contraceptives.97 Using any type of oral
contraceptive may also have a slight protective effect against
bowel cancer.98 In contrast, combined oral contraceptives
can cause a slight and transient increase in breast cancer risk,
but only for the duration of use.99 There may also be an
39
P A R T
B A C K G R O U N D
increase in the risk of cervical cancer, although this is partly related to sexual behaviour.100
Studies of women taking oestrogen-only hormone replacement therapy have suggested that the risk of endometrial
cancer is doubled after 5 years of use,101 and the risk of ovarian cancer rises by 25 per cent after the same length of use.97 102
However, use of hormone replacement therapy that
combines oestrogen and progesterone does not increase ovarian cancer risk and may even protect against endometrial
cancer.102 97 101
2.4.2.3 Radiation
40
C H A P T E R
T H E
C A N C E R
P R O C E S S
A number of medical treatments modify the risk of some cancers. As indicated in 2.4.2.3, X-rays are carcinogenic, as is
radiation used as cancer treatment.
The most notorious example has been diethylstilboestrol,
once prescribed in pregnancy and now withdrawn, which
caused cancers of the vagina and cervix of female children
born to mothers who received this drug. Treatments that
affect hormonal status have been studied extensively and are
described in 2.4.1.4. Chemotherapy as cancer treatment during childhood is followed by an increased risk of lymphoma
in adulthood.110
2.4.2.6 Carcinogenic agents in food
41
P A R T
42
B A C K G R O U N D
Unlike normal cells, cancer cells are not dependent on external growth factors to stimulate their division. Instead, they
can generate their own signals or respond to lower concentrations of external signals. This frees cancer cells from the
growth constraints of normal cells.
2.5.1.2 Insensitivity to antigrowth signals
C H A P T E R
T H E
C A N C E R
P R O C E S S
responsive genes.122
Calcium has a growth
inhibiting action on normal
and tumour gastrointestinal
cells.123 However, certain
dietary compounds can also
stimulate proliferation in
experimental cell lines, for
example, colonic cells can be
induced to hyperproliferate
by dietary haem iron.124
In a variety of animal
studies, certain dietary components have shown reductions in experimentally
induced cancers. Allyl sulphides in garlic inhibit
experimentally
induced
colon tumour formation.
Although this is not completely understood, experiments with diallyl disulphide
suggest a block in the G2/M
phase in the progression of
the cell cycle, and induction
of apoptosis.125
Fish oil supplements
decrease the number of
tumours in experimental
models of colorectal cancer.126 Long-chain n-3 PUFAs
Nutrition may influence the regulation of the normal cell cycle, which ensures correct DNA
in fish oils can limit tumour
replication. G0 represents resting phase, G1 the growth and preparation of the chromosomes for
replication, S phase the synthesis of DNA, G2 the preparation of the cell for division, and M
cell proliferation30 31 by
represents mitosis.
modifying signalling pathways,127 128 129 for example,
by decreasing signalling of
Butyrate and diallyl disulphide can act as histone deacety- activated oncogenes.130 Animals that receive a diet supplelase inhibitors16 (see 2.2.2), and arrest the cell cycle. Folate mented with n-3 fatty acids have fewer colonic tumours than
is a necessary cofactor for DNA synthesis, and deficiency can those fed a diet supplemented with corn oil,131 due to dietary
reduce cell proliferation due to decreased DNA synthesis.
fibre-altering, fatty acid-binding, protein expression in
Phenolic compounds, including genistein and EGCG, can colonocytes during tumour development.
inhibit some cyclins and cyclin-dependent kinases.118
Various growth factors and hormones involved in normal
Specifically, in people with oral leukoplakia, green tea (which cell processes can be used or produced by cancer cells to
contains EGCG) has been associated with significant decreas- maintain or augment uncontrolled cell proliferation. The
es in the size of cancers and of micronuclei formation in exfo- receptor for IGF-1 is overexpressed on many cancer cells.
liated oral cells.119
IGF-1 can enhance the growth of a variety of cancer cell
Phytoestrogens are found in high concentrations in soya lines132 by stimulating progression of the cell cycle from G1
beans, and have been shown in vitro to exhibit a plethora of to S phase.13
Insulin itself can also act as a growth factor for tumour cell
different anti-cancer effects, including inhibiting proliferation.120 121 Glucosinolates from cruciferous vegetables are con- proliferation, both by binding to the insulin receptor on canverted in the liver to ITCs, which can arrest cell cycle cer cells and by stimulating increased IGF-1 production by the
progression, as well as induce phase 2 enzymes, which can liver.13 133 Insulin resistance increases with body fatness, in
promote carcinogen excretion (see 2.3). Only about one third particular abdominal fatness, and the pancreas compensates
of people have the types of microbial flora in their gut that by increasing insulin production. This hyperinsulinaemia is
are capable of metabolising the dietary isoflavone daidzein associated with a risk of cancers of the colon and endometrito equol. Compared with Western populations, Asian popu- um, and possibly of the pancreas and kidney.13 Leptin, a horlations are more likely to produce equol, and this affects the mone produced by fat cells, can also stimulate proliferation
expression of genes involved in cell signalling and differen- of many premalignant and malignant cell types,134 as can a
tiation, and cell division. Equol can also modulate oestrogen- number of sex steroid hormones (see Chapter 6, and box 2.4).
43
P A R T
B A C K G R O U N D
44
C H A P T E R
T H E
C A N C E R
P R O C E S S
45
P A R T
Box 2.5
B A C K G R O U N D
Energy restriction
46
2.6 Conclusions
Great progress has been made since the mid-1990s in the
understanding of the cancer process. Evidence is accumulating that shows or suggests that food and nutrition, and
physical activity and associated factors, are important in
modification of the cancer process. Moreover, there is
increased evidence that specific dietary patterns, foods and
drinks, and dietary constituents can and do protect against
cancer, not only before the process starts, but also afterwards.
Understanding the mechanisms that control cell structure
and function, and so influence the cancer process, will aid
not only understanding of cancer as a whole, but also the
development of preventive strategies.